| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.65 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |